Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.

Literature DB >> 22843180

Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.

Abstract

Atrial fibrillation (AF) increases the risk of stroke. New anticoagulation agents have recently provided alternative and promising approaches. This paper reviews the current state of anticoagulation therapy in AF patients, focusing on various clinical scenarios and on comparisons, where possible, between western and eastern populations.

Entities: Disease Species

Mesh：

Substances：

Year: 2012 PMID： 22843180 PMCID： PMC3411093 DOI： 10.1631/jzus.B1201007

Source DB: PubMed Journal: J Zhejiang Univ Sci B ISSN： 1673-1581 Impact factor: 3.066

38 in total

1. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors: Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal: Circulation Date: 2006-07-03 Impact factor: 29.690

2. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

Authors: Simon Stewart; Carole L Hart; David J Hole; John J V McMurray
Journal: Am J Med Date: 2002-10-01 Impact factor: 4.965

3. A population-based study of mortality among patients with atrial fibrillation or flutter.

Authors: Humberto Vidaillet; Juan F Granada; P o-Huang Chyou; Karen Maassen; Mario Ortiz; Juan N Pulido; Param Sharma; Peter N Smith; John Hayes
Journal: Am J Med Date: 2002-10-01 Impact factor: 4.965

4. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

Authors: Carl van Walraven; Robert G Hart; Daniel E Singer; Andreas Laupacis; Stuart Connolly; Palle Petersen; Peter J Koudstaal; Yuchiao Chang; Beppie Hellemons
Journal: JAMA Date: 2002-11-20 Impact factor: 56.272

5. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors: E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal: Circulation Date: 1998-09-08 Impact factor: 29.690

6. Ochratoxin A removal from red wine by several oenological fining agents: bentonite, egg albumin, allergen-free adsorbents, chitin and chitosan.

Authors: S Quintela; M C Villarán; I López De Armentia; E Elejalde
Journal: Food Addit Contam Part A Chem Anal Control Expo Risk Assess Date: 2012-04-30

7. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors: A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal: JAMA Date: 2001-05-09 Impact factor: 56.272

Review 3. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.

Authors: Wei-Wei Xu; Shen-Jiang Hu; Tao Wu
Journal: J Zhejiang Univ Sci B Date: 2017-07 Impact factor: 3.066

3 in total

Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.

1. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

2. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

3. A population-based study of mortality among patients with atrial fibrillation or flutter.

4. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

5. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

6. Ochratoxin A removal from red wine by several oenological fining agents: bentonite, egg albumin, allergen-free adsorbents, chitin and chitosan.

7. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

8. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

9. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

10. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

1. Progress and challenges in the cardiovascular field.

2. Concurrent pulmonary thrombosis with systemic embolism: a case report.

Review 3. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.